These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7334949)

  • 1. An hypothesis of the molecular structure of the dopamine receptor.
    Smythies JR
    Med Hypotheses; 1981 Dec; 7(12):1449-56. PubMed ID: 7334949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Haloaporphines as potent dopamine agonists.
    Ramsby S; Neumeyer JL; Grigoriadis D; Seeman P
    J Med Chem; 1989 Jun; 32(6):1198-201. PubMed ID: 2524592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An hypothesis concerning the molecular structure of the nicotinic acetylcholine receptor.
    Smythies JR
    Med Hypotheses; 1980 Sep; 6(9):943-50. PubMed ID: 7432253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum.
    Niedzwiecki DM; Cubeddu LX; Mailman RB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):117-25. PubMed ID: 2746491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurotensin-like oligopeptides as potential antipsychotics: effect on dopamine system].
    Kost NV; Meshavkin VK; Batishcheva EIu; Sokolov OIu; Andreeva LA; Miasoedov NF
    Eksp Klin Farmakol; 2011; 74(10):3-6. PubMed ID: 22238978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin: peptide for the next millennium.
    Tyler-McMahon BM; Boules M; Richelson E
    Regul Pept; 2000 Sep; 93(1-3):125-36. PubMed ID: 11033059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupation of dopamine receptors by N-n-propylnorapomorphine or spiperone and acetylcholine levels in the rat striatum.
    Korf J; Sebens JB; Flentge F; van der Werf JF
    J Neurochem; 1985 Jan; 44(1):314-8. PubMed ID: 3964835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptors in rat frontal cortex: pharmacological properties in vivo and in vitro.
    Bacopoulos NG; Ware PL
    Life Sci; 1980 Dec 22-29; 27(25-26):2489-94. PubMed ID: 6163938
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists.
    De Lean A; Kilpatrick BF; Caron MG
    Mol Pharmacol; 1982 Sep; 22(2):290-7. PubMed ID: 7144730
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural differences between dopamine D2 receptors present in a rat pituitary adenoma and in transplantable rat pituitary tumors 7315a and MtTW15.
    Bouvier C; Lagacé G; Potier M; Collu R
    J Neurochem; 1990 Mar; 54(3):815-22. PubMed ID: 1968089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the function of striatal dopaminergic neurons.
    Koda H; Hashimoto T; Kuriyama K
    Jpn J Pharmacol; 1989 Feb; 49(2):215-23. PubMed ID: 2659861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J; Briley M; Langer SZ
    Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum.
    Töröcsik A; Rakovska A; Görcs T; Vizi ES
    Brain Res; 1993 May; 612(1-2):306-12. PubMed ID: 8101133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective labeling of apomorphine receptors by 3H-LSD.
    Whitaker PM; Seeman P
    Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR; Weinberger S; Segal DS; Creese I
    Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.